2
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
34
Ovarian Neoplasms
31
Peritoneal Neoplasms
28
Fallopian Tube Neoplasms
14
Colorectal Neoplasms
14
Carcinoma, Ovarian Epithelial
13
Appendiceal Neoplasms
7
Neoplasm Metastasis
5
Pancreatic Neoplasms
4
Uterine Neoplasms
3
Recurrence
3
Pseudomyxoma Peritonei
3
Neoplasms
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Peritoneal Diseases
2
Mesothelioma, Malignant
2
Mesothelioma
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastrointestinal Neoplasms
2
Gastric Adenocarcinoma
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Wilms Tumor
1
Stomach Diseases
1
Stage â…¢ Gastric Cancer
1
Stage IV Gastric Cancer With Metastasis
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Interventions
Oxaliplatin
271
Fluorouracil
268
Capecitabine
234
Leucovorin
209
Irinotecan
152
Radiotherapy
138
Bevacizumab
114
Cetuximab
82
Surgical Procedures, Operative
51
Folfox protocol
48
Neoadjuvant Therapy
45
Drug Therapy
43
Radiation
42
Chemotherapy, Adjuvant
34
Chemoradiotherapy
34
Panitumumab
27
Magnetic Resonance Spectroscopy
26
XELOX
25
Radiotherapy, Intensity-Modulated
23
Biopsy
20
Surveys and Questionnaires
18
Laparoscopy
18
Proctectomy
17
Floxuridine
17
Early Intervention, Educational
16
Nivolumab
15
Immunohistochemistry
15
Gene Expression Profiling
15
Gemcitabine
15
pembrolizumab
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled